Biogen, Inc. (BIIB)
178.35
-7.28
(-3.92%)
USD |
NASDAQ |
Jan 13, 16:00
177.97
-0.38
(-0.21%)
After-Hours: 20:00
Biogen Free Cash Flow: 2.262B for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Eli Lilly & Co. | 6.436B |
| Stoke Therapeutics, Inc. | 52.37M |
| AbbVie, Inc. | 19.68B |
| Alnylam Pharmaceuticals, Inc. | 221.36M |
| Insmed, Inc. | -906.14M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 1.272B |
| Cash from Investing (Quarterly) | -35.10M |
| Cash from Financing (Quarterly) | -130.20M |
| Free Cash Flow Per Share (Quarterly) | 8.300 |
| Free Cash Flow to Equity (Quarterly) | 1.226B |
| Free Cash Flow to Firm (Quarterly) | 1.277B |
| Free Cash Flow Yield | 8.65% |